Introduction
Measles virus (MV) is an important human pathogen that is still the cause of up to one million deaths each year, despite the encouraging progress towards control of measles in several areas of the world and the WHO Expanded Programme on Immunization (EPI). MV is considered to be serologically monotypic, although wild-type isolates are known to be genetically heterogeneous and several genotypes have been identified (Rima et al., 1995 ; Taylor et al., 1991 ; Rota et al., 1994) . These genetic differences have provided a basis for molecular epidemiological studies of MV. Several methods have been described for obtaining sequence information following RT-PCR amplification of MV RNA in a variety of clinical samples (Shimizu et al., 1993 ; Nakayama et al., 1995 ; Jin et al., 1996) . MV lineages have a geographical basis (Rima et al., 1995) and analysis of the sequence data obtained from wildtype viruses has been used to identify the source of the virus and to confirm epidemiological links between cases in outbreaks (Rota et al., 1995 ; Jin et al., 1996) . For example, the majority of viruses associated with the resurgence of MV in the United States (US) between 1989 and 1992 were of a single genotype, and isolates from different outbreaks in the US during 1994 were representatives of four different lineages, suggesting that they had been recently introduced by importation (Rota et al., 1995) . All these studies were based on analysis of the C terminus of the nucleoprotein (N) and the haemagglutinin (H) genes.
In this study, we have investigated the molecular epidemiology of MV in the United Kingdom (UK) by sequencing the N and matrix (M) gene amplicons following PCR directly from clinical samples. MV strains were analysed between 1992 and 1995 with the aim of describing the indigenous UK strains prior to the measles and rubella (MR) vaccination campaign of 1994, to establish when circulation of these strains was interrupted, and to facilitate epidemiological investigation of suspected MV importations.
Methods
Specimens and virus strains. MV sequences were obtained from 50 clinical specimens by RT-PCR. All specimens were collected from serologically confirmed measles cases including 16 throat swabs (TS), seven urine samples, five EDTA-treated whole blood samples (including two separated leukocyte preparations), 16 saliva samples and three nasopharyngeal aspirates (NPA). Three MV isolates were grown from the same samples in tissue culture (TC), in either Vero cells or B95a cells (an Epstein-Barr virus-transformed marmoset lymphoblastoid cell line ; Kobune et al., 1990) . Table 1 (a) shows the origin, characterization and accession numbers of these 50 UK MV strains, including the 12 previously reported . The origin and characterization of a number of previously described measles strains used for comparison in 0001-4567 # 1997 SGM et al., 1991) , CL and TT (Schulz et al., 1992) ; four MV strains from the US, JM, TN, Chi1 and CO (Rota et al., 1996) ; two Spanish MV strains, Ma94b and Ma93f (Rima et al., 1995) , the prototype MV isolate, Edmonston strain (Ed-w) (Enders et al., 1954) ; Moraten (Morv), a vaccine strain currently used in the UK, and a Russian isolate, Loss strain, which was used as a positive control throughout the studies.
BCIH
RT-PCR used to detect MV sequences directly in clinical samples. MV RNA was extracted from a variety of clinical specimens using the guanidinium thiocyanate-silica method as described by Boom et al. (1990) . The MV RNA was then transcribed using Moloney murine leukaemia virus reverse transcriptase and random hexamers as primers. Specific M gene primers (Mm1, Mm2R, Mm3 and Mm4R) and the N gene primers (Mn1, Mn2R, Mn3 and Mn4R) were used in a nested dualtarget PCR to produce amplicons of 152 bp and 255 bp, respectively, as described previously .
RT-PCR used to amplify the entire MV N gene. The MV RNA of two UK strains (UK63\94 and UK67\93) was extracted from clinical specimens (TS and NPA) and reverse transcribed as described above. The 1500 nucleotides (nt) of the N gene were amplified by the nested PCR using primers N5 (5h cacgcgaattcgagcaggattaggcatatccgagatg) and N3 (5h cacgcctcgagcggcctctcgcacctagtctag) (Rota et al., 1994) for the firstround PCR and primers N5 (5h agatggccacacttttaaggagcttagcat) and N3-1R (5h tctcgcacctagtctagaagatttctgtca) for the nested PCR. The primers were selected to flank the N gene from the initial nucleotide to nt 1694 of the N gene according to the sequence of the Ed-w strain (Billeter et al., 1984) . The PCR cycle used was an initial denaturation for 2 min at 95 mC followed by 30 cycles of 1 min at 94 mC, 2 min at 50 mC (for the first round) or 55 mC (for the nested round), and 3 min at 72 mC. Nucleotide sequence determination. The PCR products were cut from agarose gels, purified using a GeneClean Kit by following the instructions of the supplier (Bio 101) and sequenced directly. The nucleotide sequences were determined using the Taq DyeDeoxyterminator cycle sequencing kit with the forward and reverse primers for the nested PCR and internal primers constructed for the entire N gene (Rota et al., 1994) in an ABI 373A automatic DNA sequencer (Applied Biosystems).
Computer analysis. Nucleotide and deduced amino acid sequences were analysed with the SeqEd version 1.0.3 program ; the Clustal routine of Megalign, a multiple-alignment program in the DNASTAR package, was used for construction of the M gene tree. DNA distances for the N gene were calculated and analysed with the DNAdist and Fitch programs from the Phylip package, which estimates phylogenies from distance matrix data under the additive tree model. The unrooted trees were drawn with the DrawTree program of Phylip.
Results

Sequence analysis of the N gene
The entire N gene sequences of two strains, UK67 and UK63, were determined directly and the data were submitted to GenBank (see the accession numbers in Table 1 a). There is 2 % and 3n3 % divergence in the amino acid (aa) sequence (aa 16-505 of the N gene) between strains Ed-w and UK67 and UK63, respectively. The area of greatest variation (7n1 % and 8n3 % divergence for UK67 and UK 63) was detected in the Cterminal region (aa 421-505) of the N gene. The divergence between UK67 and UK63 is 4n3 % across the 489 aa region (aa 16-505) and 14n1 % in the C-terminal 85 aa region (aa 421-505).
Sequences obtained from the most variable region, the C terminus (aa 421-505) of the N gene, from 20 UK strains over the period 1974-1995, were compared using the Phylip program. Fig. 1 shows a phylogenetic analysis of these strains. Three distinct lineages were detected amongst the UK strains identified during 1992-1995. One strain, UK343, which was obtained from a vaccinee, was identical to the Mor-v strain. The UK strains in these three lineages were related to the US strain NJ1 and the Spanish strain Ma94b (UK genotype I), US strains JM and TN and Spanish strain Ma93f (UK genotype II) and US strains Chi1 and CO (UK genotype III), and all were distinct from the vaccine strain.
The region of the N gene analysed in this study encoded a B cell epitope between aa 457 and 476 (Buckland et al., 1989) . We observed a Leu to Pro (aa 467) and a Gly to Asp (aa 470) change in genotype II strains, and a Gly to Ser (aa 470) change in genotype II and III strains. This epitope has previously been reported to be variable in isolates CL and TT and some African strains (Giraudon et al., 1988 ; Schulz et al., 1992) .
Temporal changes in the N sequence in the UK during 1974-1995
The amino acid differences in the C terminus of N genes were compared between current strains representing the three genotypes and previous reported MV strains isolated in the UK during 1974-1995. Strains UK234 and MVO isolated in 1995 and 1974 respectively diverged by 4n7 % over aa 421-505 at the C terminus of the N gene. Strains Ed-w and UK234 diverged by 7n1 % and strains Ed-w and MVO by 4n7% over the same region. Comparing the C-terminal N gene sequences of the UK strains isolated during 1974-1995, it should be noted that although the UK strains S33 and S81 were both isolated from brains of subacute sclerosing panencephalitis (SSPE) patients during the 1980s, the patients were likely to have acquired the infection during the 1960s or 1970s. Strain MVO is closely related to the current strains of UK genotype I. Strains CL and TT are related to the current UK genotype III but are no longer circulating in the UK. Viruses of genotype II have not been identified previously in the UK.
Sequence analysis of the M gene
The M gene exhibited less sequence variation than the N gene. However, RT-PCR using the primers for the M gene is more sensitive than that using the primers for the N gene , enabling a wider range of MV strains to be characterized (Fig. 2) .
Nucleotide sequences were determined for nt 130-281 (152 nt) of the M gene from 49 of 50 contemporary UK strains obtained between 1992 and 1995 (no M sequence data were available for UK139) and compared with ten previously published sequences (Ed-w, Mor-v, Loss, SE, TT, JM, Chi1, NJ, TN and CO). Fig. 2 shows the relatedness of the 152 nt M gene sequences as determined using the Clustal routine of the Megalign program. The M gene sequences clustered into three distinct lineages, which is similar overall to the clustering generated with the N gene sequences. The relatedness of the M and N gene sequences of these strains was further analysed with the Fitch program from the Phylip package and with the Clustal program of Neighbour-joining trees : no difference in the construction of the trees was apparent (results not shown).
UK genotypes of MV
Of viruses belonging to three distinct MV lineages detected in the UK on the basis of the M gene sequence (Fig. 2 ), 19 were characterized as genotype I, similar to strain NJ, a 1994 MV isolate from the US (Group 4 based on the sequences of the H gene ; Rota et al., 1995) . These 19 strains were detected from five outbreaks and five sporadic cases between April 1992 and December 1995. Analysis of the M (18 of the 19 strains) and the N (seven of the 19 strains) genes showed limited genetic heterogeneity within this group (divergence 0n0-0n7 % for the M gene and 0n0-1n1 % for the N gene) over the 3 years of this study.
Eighteen strains characterized as UK genotype II were very similar to strains JM and TN, isolated in the US in 1977 and 1994 (Group 5 based on the sequences of the H gene ; Rota et al., 1995) . These included four identical strains obtained from two outbreaks and 14 strains from sporadic cases during 1992-1995. The sequence divergence within this group was up to 2n6 % amongst 18 strains for the M gene and 1n1% amongst four strains for the N gene during this 3 year period.
Eleven MV strains characterized as genotype III were similar to strains Chi1 and CO isolated in the US in 1989 and 1994, respectively (Groups 2 and 3 based on the sequences of the H gene ; Rota et al., 1995) . Analysis of both the M and N genes indicates that this group is more diverse, with strains diverging by up to 3n9 and 4n3 % respectively. This may represent three distinct subgenotypes on the basis of the unrooted trees. All MV genotype III strains were from sporadic cases. Genotype IIIa includes five strains (UK140, 160, 226, 237 and 288) and genotype IIIc includes five strains (UK349, 362, 264, 298 and 260) that were found to be distinct from the US strains Chi1 and CO, and from the previously reported UK strains TT and CL (Schulz et al., 1992) . One strain, UK296 (genotype IIIb), was found to have an M gene sequence identical to that of the US strain CO (Fig. 2) .
The Ed-w-like group of MV strains are presented in this study for comparison. This group contains the Edmonston strain itself, which has been widely used as a vaccine strain, the Mor-v strain (an Ed-w-derived vaccine strain) and the Loss strain, originally isolated in Russia in 1988, which was used as the positive control in all experiments. Two of the UK strains (UK343 and UK354) examined in this study were identical to the Mor-v strain. Both UK343 (the M and N genes) and UK354 (the M gene only) were detected in saliva samples collected from a 14-month-old and a 12-month-old infant respectively, who had been vaccinated 10 days previously and had developed a measles-like illness. This is the first description of the detection of sequences of an MV vaccine strain in saliva. Further studies of MV vaccinees are in progress.
Although some nucleotide changes detected in the M gene were silent changes, the 49 UK MV strains are divided into three major groups which are significantly different from the Ed-w-like group (Fig. 2) . The close clustering of strains is related to their date of collection and geographical location. The virus sequences detected from the specimens collected from the same outbreak were always identical, e.g. strains UK3 and UK5 (Morpeth ; 1994), UK67 and UK74 (Trafford ; 1993) and UK96 and UK99 (Oxford ; .
A few cases and outbreaks were epidemiologically linked to imported infection. The MV sequences identified in two Spanish students (UK294 and UK295) were identical to the Spanish strain Ma94b (Rima et al., 1995) and to an Italian strain (G. Nigro, personal communication), suggesting that genotype I is circulating widely in Europe. A novel strain (UK296, genotype IIIb) was found in a student who had recently returned from Portugal in July 1995. This strain has not been previously identified in Europe and there are no sequence data available for contemporary MV strains in Portugal.
Discussion
No widely accepted scheme has been described for classifying MV genotypes. Rima et al. (1995) proposed seven distinct MV genotypes on the basis of phylogenetic analysis of the N gene sequences. Rota et al. (1994) described several related groups of MV strains and defined them as genotypes, which had at least 1n5 % divergence in the C-terminal region of the N gene. In this study, we have defined three genotypes on the basis of phylogenetic comparisons. The degree of divergence between genotypes was between 3n5-16n0 % and 2n6-7n9 % for the N and M genes respectively. Rima et al. (1995) suggested that geographical origin affected MV diversity but were unable to identify changes linked to temporal factors. The close similarity of MV genotype I strains identified here over a 3 year period and with MV strains reported earlier is consistent with a low rate of mutation. In contrast, MV strains belonging to genotype III were more diverse and may represent three distinct subgenotypes, IIIa, IIIb and IIIc (Table 1 a) . Table 1 (b) shows the relationship between the genotypes classified by Rima et al. (1995) and the genotypes classified in this study.
We identified the greatest diversity among MV strains in the C terminus of the N gene, as has been reported by others (Taylor et al., 1991 ; Rota et al., 1994 ; Rima et al., 1995) . However, similar lineages were generated using the M and N gene sequences which indicates a lack of recombination and suggests that both genes can be used for phylogenetic analysis. This has an important practical implication because direct sequencing of PCR products of the M gene is more sensitive than the N gene PCR . We report here for the first time the detection of MV sequences in saliva samples. This reflects the greater sensitivity of M gene RT-PCR and is the first direct evidence of measles vaccine replication in the upper respiratory tract. We obtained identical sequences directly from clinical samples and following virus culture from three MV isolates. However, it is well-established that passaging MV in cell culture can lead to changes in the pathogenicity of the virus including increased infectivity (Kobune et al., 1990 ; Forthal et al., 1993) and phenotypic changes such as HeLa cell fusion and CD46 downregulation (Shibahara et al., 1994 ; Lecouturier et al., 1996) . The method used here of sequencing the RT-PCR amplicons directly from clinical specimens avoids the need to culture the virus, may generate more representative results and facilitates the characterization of increased numbers of strains, which may be important for surveillance. The greater sensitivity of M gene PCR is of note and may be due to the smaller product size or reflect the lower level of sequence diversity in the M gene.
We have identified a shift in the pattern of MV genotypes between 1992 and 1995 (Table 2) . Genotype I strains have been detected in the UK and also in Spain (Rima et al., 1995) and in Italy (G. Nigro, personal communication), indicating that this lineage has been circulating widely across Europe during this period. The differences observed between earlier and contemporary strains characterized as genotype III suggest a shift in the pattern of circulation of viruses within this group. The emergence of genotype II strains in the UK may be a real observation, but because of the paucity of data in earlier years it remains a possibility that genotype II strains have been circulating undetected in the UK in the past. These changes suggest that the geographical range of MV strains may shift over time. This reflects the changing patterns of infection, since MV is now circulating in adolescents and young adults, who are more mobile than young children and can disseminate virus further.
One additional MV genotype that has been detected in the UK during the same period (Outlaw & Pringle, 1995) is closely related to the Ed-w or vaccine group based on the sequences of the H gene. Wild-type strains belonging to the Ed-w genotype have been found in China in 1993 (unpublished results), so this may represent an importation of this genotype. We have not identified this genotype subsequently, suggesting that it has not continued to circulate in the UK. The truncation of the H protein of MV strains (Outlaw & Pringle, 1995) has been previously detected in some SSPE strains (Schmid et al., 1992 ; Billeter et al., 1994) .
The results obtained in this study indicate that monitoring the distribution of MV genotypes may provide useful information for measles surveillance programmes. In the epidemiological context of the UK following the MR mass vaccination programme in November 1994, MV circulation has been well controlled. However, strains belonging to three distinct lineages of MV have still been identified. Since 1994, MV outbreaks have been small in scale and the observed variation in the UK strains fits best with repeated introduction of MV strains from other countries. Since widespread MV infection is taking place in several countries in western Europe, this situation is likely to continue for some time. The geographical range of MV genotypes is not known, but genotype I has circulated across Europe in recent years which can frustrate attempts to track importation of these strains. As control of MV infection worldwide improves, the study of the diversity and pattern of MV transmission is likely to contribute useful information to measles surveillance programmes.
